Table 2.
Adjusted mean HRQOL scores in study sample
| |
CKD stage 1–2 (eGFR ≥60) |
CKD stage 3 (60 >eGFR ≥ 30) |
CKD stage 4 (30 >eGFR ≥ 15) |
CKD stage 5 (eGFR<15) |
|
|---|---|---|---|---|---|
| Sample | Mean EQ-5Dindex | P-value | |||
|
US |
0.83 |
0.85 |
0.78 |
0.72 |
0.04 |
| UK | 0.64 | 0.58 | 0.49 | 0.28 | 0.02 |
Adjusted mean EQ-5Dindex scores by kidney function classes. Means estimated with general linear models. Confidence levels refer to partial Spearman’s correlation coefficient. All models have been adjusted for age, gender, months since transplant, diagnosis of diabetes, hypertension, cardiovascular diseases, anxiety/depression and center of enrollment. The interaction term between center and CKD classes was not statistically significant.